Medtronic (MDT +0.23%), one of the largest medical-device players on the planet, reported its fourth-quarter earnings today, and investors were clearly pleased with the results. Shares were up 4.9% by the market close, and this stock is up more than 30% over the past 12 months. But which segments drove the company's business in Q4? How did Medtronic's results measure up against its medical-device peers, like Boston Scientific (BSX +0.21%) and St. Jude Medical (STJ +0.00%)? Health-care analyst Max Macaluso discusses these topics in the following video.
What's Behind Medtronic's 5% Pop?
By Max Macaluso – May 21, 2013 at 6:30PM
NYSE: MDT
Medtronic
Market Cap
$116B
Today's Change
(0.23%) $0.21
Current Price
$90.41
Price as of November 4, 2025 at 3:58 PM ET
Fourth-quarter results impressed investors today.
About the Author
Max is the Technology, Biopharma & Health Care Bureau Chief at Fool.com. Prior to joining the Fool, he completed a PhD in chemistry at the University of Cambridge and an MBA at the College des Ingenieurs.
Follow @TMFMassimo